Aptevo Therapeutics Inc. Total Long-Term Debt
Aptevo Therapeutics Inc. (APVO) had Total Long-Term Debt of $0 as of 2023-12-31, per its 10-K filed 2024-03-05.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2024-03-05
- 2023-12-31: Long-term Debt $0.00.
- 2023-09-30: Long-term Debt $0.00.
- 2023-06-30: Long-term Debt $0.00.
- 2023-03-31: Long-term Debt $0.00.
| Period end | Long-term Debt |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-05 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 |
| 2022-12-31 | $4.01M 10-K · filed 2023-03-30 |
| 2021-12-31 | $16.02M 10-K · filed 2022-03-24 |
| 2020-12-31 | $28.22M 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |